Peter J. Hosein

3.7k total citations · 1 hit paper
111 papers, 2.4k citations indexed

About

Peter J. Hosein is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter J. Hosein has authored 111 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Oncology, 37 papers in Cancer Research and 29 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter J. Hosein's work include Pancreatic and Hepatic Oncology Research (50 papers), Cancer Genomics and Diagnostics (33 papers) and Neuroendocrine Tumor Research Advances (13 papers). Peter J. Hosein is often cited by papers focused on Pancreatic and Hepatic Oncology Research (50 papers), Cancer Genomics and Diagnostics (33 papers) and Neuroendocrine Tumor Research Advances (13 papers). Peter J. Hosein collaborates with scholars based in United States, United Kingdom and Netherlands. Peter J. Hosein's co-authors include Govindarajan Narayanan, Caio M. Rocha Lima, Jill Lacy, Jaime R. Merchan, Bassel F. El‐Rayes, Casper H.J. van Eijck, Bas Groot Koerkamp, Mustafa Suker, Ian Chau and Jason E. Faris and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Peter J. Hosein

99 papers receiving 2.3k citations

Hit Papers

FOLFIRINOX for locally advanced pancreatic cancer: a syst... 2016 2026 2019 2022 2016 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
    2016 653 citations Peter J. Hosein et al. profile →

Peers

Peter J. Hosein
Arantza Fariña Sarasqueta Netherlands
Johanna W. Wilmink Netherlands
Kristen K. Ciombor United States
Jifang Gong China
Alison Backen United Kingdom
Αthanasios Kotsakis Greece
Osama E. Rahma United States
Vinod Ganju Australia
Changping Wu China
Fabio Gelsomino Italy
Arantza Fariña Sarasqueta Netherlands
Peter J. Hosein
Citations per year, relative to Peter J. Hosein Peter J. Hosein (= 1×) peers Arantza Fariña Sarasqueta

Countries citing papers authored by Peter J. Hosein

Since Specialization
Citations

This map shows the geographic impact of Peter J. Hosein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Hosein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Hosein more than expected).

Fields of papers citing papers by Peter J. Hosein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Hosein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Hosein. The network helps show where Peter J. Hosein may publish in the future.

Co-authorship network of co-authors of Peter J. Hosein

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Hosein. A scholar is included among the top collaborators of Peter J. Hosein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Hosein. Peter J. Hosein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Widerström-Noga, Eva, Jessica Bolanos, Gabriel González, et al.. (2025). Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy. Frontiers in Pain Research. 5. 1516196–1516196. 3 indexed citations
2.
Yu, Qian, Fan Cao, Peter J. Hosein, et al.. (2025). Dethroning of Neuroendocrine Tumor as an Orphan Disease: US Incidence, Prevalence, and Survival in the 21st Century. Cancers. 17(20). 3323–3323. 1 indexed citations
3.
4.
Hosein, Peter J., Michael Rothe, Elizabeth Garrett‐Mayer, et al.. (2025). Nivolumab plus ipilimumab (N+I) in patients (pts) with pancreatic cancer (PC) with BRCA1/2 mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.. Journal of Clinical Oncology. 43(4_suppl). 715–715. 1 indexed citations
5.
McTeague, Lisa M., Gabriel González, Jessica Bolanos, et al.. (2025). Transcranial magnetic stimulation measures of corticospinal excitability in Black and Hispanic/Latino people with painful peripheral neuropathy. Frontiers in Human Neuroscience. 19. 1551931–1551931.
6.
Yanala, Ujwal, Joseph F. Pizzolato, Alan S. Livingstone, et al.. (2024). Utility of tumor-informed circulating tumor DNA for detection of minimal residual disease after curative-intent therapy in localized pancreatic cancer. 2(1). 100116–100116. 1 indexed citations
7.
Faber, Erik B., Peter J. Hosein, Anthony F. Shields, et al.. (2024). Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic Targets. JCO Precision Oncology. 8(8). e2300595–e2300595. 3 indexed citations
8.
George, Thomas J., Ji‐Hyun Lee, David L. DeRemer, et al.. (2024). Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms. JCO Precision Oncology. 8(8). e2400406–e2400406. 6 indexed citations
9.
10.
Florou, Vaia, Andrew Elliott, Matthew H. Bailey, et al.. (2023). Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC. Clinical Cancer Research. 29(17). 3408–3417. 10 indexed citations
11.
Lu, Heng, Dunfa Peng, Mohammed Soutto, et al.. (2023). Smoking induces WEE1 expression to promote docetaxel resistance in esophageal adenocarcinoma. Molecular Therapy — Oncolytics. 30. 286–300. 2 indexed citations
12.
Florou, Vaia, Charalampos S. Floudas, Asaf Maoz, et al.. (2023). Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden. Journal for ImmunoTherapy of Cancer. 11(8). e007440–e007440. 9 indexed citations
13.
Husnain, Muhammad, Wungki Park, Juan Carlos Ramos, et al.. (2018). Complete response to ipilimumab and nivolumab therapy in a patient with extensive extrapulmonary high-grade small cell carcinoma of the pancreas and HIV infection. Journal for ImmunoTherapy of Cancer. 6(1). 66–66. 21 indexed citations
14.
Edwards, Jason, et al.. (2016). Superior Outcomes With Gemcitabine-Based Systemic and Concurrent Administration With Radiation Therapy in Inoperable or Unresectable Cholangiocarcinomas. International Journal of Radiation Oncology*Biology*Physics. 96(2). E207–E208.
15.
Koru‐Sengul, Tulay, Feng Miao, Olveen Carrasquillo, et al.. (2016). Colorectal Tumors From Different Racial and Ethnic Minorities Have Similar Rates of Mismatch Repair Deficiency. Clinical Gastroenterology and Hepatology. 14(8). 1163–1171. 22 indexed citations
16.
Venkat, Shree, Peter J. Hosein, & Govindarajan Narayanan. (2015). Percutaneous Approach to Irreversible Electroporation of the Pancreas: Miami Protocol. Techniques in vascular and interventional radiology. 18(3). 153–158. 10 indexed citations
17.
Loaiza‐Bonilla, Arturo, Muaiad Kittaneh, Mauricio A. Escobar, et al.. (2014). Successful use of Trastuzumab with anthracycline-based chemotherapy followed by trastuzumab maintenance in patients with advanced HER2-positive gastric cancer.. PubMed. 34(1). 301–6. 14 indexed citations
18.
Hosein, Peter J., et al.. (2012). Progressive multifocal leukoencephalopathy following treatment with bendamustine and rituximab. International Journal of Hematology. 96(2). 274–278. 10 indexed citations
19.
Hosein, Peter J., Jessica MacIntyre, Vinicius Ernani, et al.. (2012). A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma. BMC Cancer. 12(1). 199–199. 176 indexed citations
20.
Hosein, Peter J. & Caio Rocha‐Lima. (2008). Role of Combined-Modality Therapy in the Management of Locally Advanced Rectal Cancer. Clinical Colorectal Cancer. 7(6). 369–375. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arantza Fariña Sarasqueta Breakdown of academic impact, for papers by Johanna W. Wilmink Breakdown of academic impact, for papers by Kristen K. Ciombor Breakdown of academic impact, for papers by Jifang Gong Breakdown of academic impact, for papers by Alison Backen Breakdown of academic impact, for papers by Αthanasios Kotsakis Breakdown of academic impact, for papers by Osama E. Rahma Breakdown of academic impact, for papers by Vinod Ganju Breakdown of academic impact, for papers by Changping Wu Breakdown of academic impact, for papers by Fabio Gelsomino
Rankless by CCL
2026